State Medicaid Outpatient Drug Utilization and Reimbursement Data, 2005

State-reported drug utilization data for Medicaid-covered outpatient drugs since the start of the Medicaid Drug Rebate Program. The dataset includes state, drug name, National Drug Code, number of prescriptions, and dollars reimbursed. It is provided by the U.S. Department of Health & Human Services and was last updated on the platform in April 2026.

Use Cases

• Analyze state-level prescription volumes and costs based on the reported number of prescriptions and dollars reimbursed.
• Track pharmaceutical market share within Medicaid based on drug name and National Drug Code identifiers.
• Compare drug utilization and spending patterns across different states.
• Study the impact of the Medicaid Drug Rebate Program on outpatient drug expenditures.

Strengths

• Data is reported by state Medicaid agencies, suggesting an official administrative source.
• Includes key financial and volume metrics: number of prescriptions and dollars reimbursed.
• Covers the period since the start of the Medicaid Drug Rebate Program, providing longitudinal context.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

U.S. Department of Health & Human Services, via state Medicaid agencies.

Collection Method

Reported by states for covered outpatient drugs paid for by Medicaid.

Time Range

Since the start of the Medicaid Drug Rebate Program; the dataset title specifies 2005.

Freshness

Last updated 2026-04-08 20:33:25.192346; freshness should be verified.

Geography

United States, reported by state.